N/A
N=65
Continuous Non-Invasive Measurement of Hemoglobin During Parturition
Hemorrhage · Cesarean Section
Bottom Line
View on ClinicalTrials.gov: NCT03150043 ↗Enrolled (actual)
65
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcome: Primary: Pearson Correlation Coefficient for Hemoglobin Measurements — 0.6 Correlation Coeficient
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Masimo Rainbow Pulse CO-oximeter (Device)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- The University of Texas Medical Branch, Galveston
- Primary completion
- May 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pearson Correlation Coefficient for Hemoglobin Measurements |
0.6 | — |
| SECONDARY Number of Participants Who Required Blood Transfusion |
65 | — |
Summary
A non-invasive hemoglobin monitor will be used during cesarean delivery and the values obtained will be compared to values obtained from traditional blood draw.
Eligibility Criteria
Inclusion Criteria
- Pregnant women undergoing primary cesarean delivery after failed induction of labor, or repeat cesarean delivery after failed TOLAC (trial of labor after cesarean)
- Pregnant women between the ages of 18-50
Exclusion Criteria
- Patient who are not pregnant
- Patients unwilling or unable to provide consent
- Patients under the age of 18
- Patients who are incarcerated
Data sourced from ClinicalTrials.gov (NCT03150043). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.